Home > Back to Publisher > Report Information

Monoclonal Antibody Based Products - Global Trends

BizAcumen, Inc.
November 1, 2009
299 Pages - SKU: BZAC2522192

Abstract Table of Contents Related Reports

Countries covered: Global

Monoclonal antibodies represent one of the successes of the biotechnology industry along with a broad range of therapeutics and diagnostics. Monoclonal Antibody (MAb)-based products market is one of the fastest growing categories of the biopharmaceuticals industry. These products are of high significance for pharmaceutical industry, both in research as well as drug development activities. MAbs function as production repositories for developing drugs, and are used in the manufacture of highly specialized diagnostic products. Rapid technological advancements that enable antibodies to specifically target disease-causing cells are expected to boost prospects in the global therapeutic and diagnostic monoclonal antibodies market.

These and other market data and trends are presented in "Monoclonal Antibody-Based Products: Global Trends" by BizAcumen LLC. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

1. METHODOLOGY: Study Reliability and Reporting Limitations; Disclaimers; Quantitative Techniques & Reporting Level
2. GLOBAL MARKET OVERVIEW AND OUTLOOK: MAb Market - Set for Significant Growth; Therapeutic mAb Market - Principal Driving Force; Genomics Research Leads Way to New Monoclonal Antibodies; Bright Outlook for Mabs; Current and Future Analysis; Competitive Scenario; Drug Developers Trying to Break the Shackles; A Revolution Not too Far…; Milestones in Development of MAbs; Focus on Unmet Medical Needs in the Emerging Markets
3. TRENDS AND ISSUES: Shift Towards Humanized and Fully Human Antibodies; Ageing Baby Boomers Spur MAbs Growth; Non-Existent Generic Competition Favors MAb Market; Partnerships and Collaborations Spark Increase in Profit Margins; Pharma Majors & CMOs Augment Investment in Mab Production; Rising Number of MAbs Under Clinical Trials; High Costs Impede MAbs Penetration; Opportunities in Technology Development; Advancements & Challenges in Antibody Production Processes; Increasing Demand for Protein A in Mab Manufacturing; FCA- A Major Cause for Discomfort in Mice; Innovations to Drive Growth in Anti-Ovarian Cancer Drugs Market; Rising Incidence of NHL to Drive Monoclonal Antibody Drug Market
4. PRODUCT FACTS: A. Therapeutics; B. Diagnostics; Types of Monoclonal Antibodies
5. CORPORATE DEVELOPMENTS: Callisto Merger Corporation Merges with Celldex Therapeutics; SDI to Develop mAbs for SAIC-F and NCI; HGS Reacquires Rights for TRAIL Receptor Antibodies; Amgen Enters into Licensing Agreement with Kyowa Hakko; Dyax and Sanofi-Aventis Sign Agreements; HGS Enters into Antibody Collaboration Agreement with Xencor; Amgen Introduces Vectibix; UCB Receives FDA Approval for Cimzia®; Genentech Acquires Tanox; Biotest Acquires Assets of Nabi Biologics; CMC Acquires ICOS Biologics Operation; Roche Takes Over THP; GTC and LFB Commence CD20 Monoclonal Antibody Development; Amgen Inks Collaboration and License Pact with Daiichi Sankyo; CMC Biopharmaceuticals Inks Agreement with Morphotek; CMC Biopharmaceuticals Inks Agreement with Biotest; Eli Lilly Collaborates with MacroGenics; Genentech Inks Global Licensing Agreement with Seattle Genetics
6. MAJOR PLAYERS: Amgen, Inc. (US); BD Biosciences (US); Biogen Idec Inc (US); Biotest AG (Germany); CMC ICOS Biologics, Inc.; Dendreon Corporation (US); Elan Corporations Plc (Ireland); Eli Lilly and Company (US); Genentech, Inc. (US); Human Genome Sciences, Inc. (US); Immunomedics, Inc. (US); Johnson & Johnson (US); Medarex, Inc. (US); MedImmune, Inc. (US); PDL BioPharma (US); Schering-Plough Corporation (US); Strategic Diagnostics Inc (US); UCB Group (Belgium); Wyeth Pharmaceuticals (US)
7. MARKET ANALYTICS
8. THE UNITED STATES: Therapeutic Monoclonal Antibodies Market - An Overview
9. CANADA
10. JAPAN
11. EUROPE: a.France; b.Germany; c.Italy; d.The United Kingdom; e.Rest of Europe
12. REST OF WORLD: Australia; India
EXHIBITS: Table 1: Major Acquisitions of Antibody-Focused Companies - 2007; Table 2: Market Shares of Leading Players in the Global Monoclonal Antibody Therapy Market - 2005; Table 3: Market Shares of Leading Drugs in the Global Therapeutic Monoclonal Antibodies Market - 2006; Table 4: Market Shares of Leading Antibody Based Products Manufacturers in the World - 2004; Table 5: Market Shares of Leading Drugs in the Global Monoclonal Antibody Based Products Market - 2004; Table 6: Market Shares of Leading Oncology Monoclonal Antibodies Products in the World - 2008E; Table 7: Market Shares of Leading Antibody-Based Anti-InflammatoryProducts in the World - 2006; Table 8: Global Mab Market by Product Type - 2008; Table 9: Market Shares of Monoclonal Antibody Therapies in the World - 2010E; Table 10: Global Market for Monoclonal Antibody Based Products by Region for the Period 2007-2015 (Sales in US$ Million); Table 11: Percentage Breakdown of Global Market for Monoclonal Antibody Based Products by Region for the Years 2008 & 2012; Table 12: Global Therapeutics Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 13: Percentage Breakdown of Global Therapeutics Market by Region for the Years 2008 & 2012; Table 14: Global Therapeutic Monoclonal Antibody Based Products Market by Segments for the Period 2007- 2015 (Sales in US$ Million); Table 15: Percentage Breakdown of Global Therapeutic Monoclonal Antibody Based Products Market by Segments for the Years 2008 & 2012; Table 16: Global Cancer Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 17: Percentage Breakdown of Global Cancer Market by Region for the Years 2008 & 2012; Table 18: Global Other Therapeutic Monoclonal Antibody Based Products Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 19: Percentage Breakdown of Global Other Therapeutic Monoclonal Antibody Based Products Market by Region for the Years 2008 & 2012; Table 20: Global Diagnostics Market by Region for the Period 2007-2015 (Sales in US$ Million); Table 21: Percentage Breakdown of Global Diagnostics Market by Region for the Years 2008 & 2012; Table 22: Market Shares of Leading Therapeutic Monoclonal Antibodies Products in the US - 2007; Table 23: Market Shares of Leading Therapeutic Monoclonal Antibodies Products Manufacturers in the US - 2007; Table 24: Monoclonal Antibody Based Products Market by Segment in the US: 2007-2015 (Sales in US$ Million); Table 25: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in the US for the Years 2008 & 2012; Table 26: Monoclonal Antibody Based Products Market by Segment in Canada: 2007-2015 (Sales in US$ Million); Table 27: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in Canada for the Years 2008 & 2012; Table 28: Monoclonal Antibody Based Products Market by Segment in Japan: 2007-2015 (Sales in US$ Million); Table 29: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in Japan for the Years 2008 & 2012; Table 30: Monoclonal Antibody Based Products Market by Region in Europe: 2007-2015 (Sales in US$ Million); Table 31: Percentage Breakdown of Monoclonal Antibody Based Products Market by Region in Europe for the Years 2008 & 2012; Table 32: Monoclonal Antibody Based Products Market by Segment in Europe: 2007-2015 (Sales in US$ Million); Table 33: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in Europe for the Years 2008 & 2012; Table 34: Monoclonal Antibody Based Products Market by Segment in France: 2007-2015 (Sales in US$ Million); Table 35: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in France for the Years 2008 & 2012; Table 36: Monoclonal Antibody Based Products Market by Segment in Germany: 2007-2015 (Sales in US$ Million); Table 37: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in Germany for the Years 2008 & 2012; Table 38: Monoclonal Antibody Based Products Market by Segment in Italy: 2007-2015 (Sales in US$ Million); Table 39: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in Italy for the Years 2008 & 2012; Table 40: Monoclonal Antibody Based Products Market by Segment in the UK: 2007-2015 (Sales in US$ Million); Table 41: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in the UK for the Years 2008 & 2012; Table 42: Monoclonal Antibody Based Products Market by Segment in Rest of Europe: 2007-2015 (Sales in US$ Million); Table 43: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in Rest of Europe for the Years 2008 & 2012; Table 44: Monoclonal Antibody Based Products Market by Segment in Rest of World: 2007-2015 (Sales in US$ Million); Table 45: Percentage Breakdown of Monoclonal Antibody Based Products Market by Segment in Rest of World for the Years 2008 & 2012
COMPANIES PROFILED

More Global Antibody Technologies Reports

Global Protein Therapeutics Market Forecast to 2015 by RNCOS
Protein-based therapies have found a prominent place in the biopharmaceutical industry since the launch of human insulin product. They have become one of the most ...

Antibody Drugs: Technologies and Global Markets by BCC Research
The global market for therapeutic monoclonal antibodies (mAbs) was estimated at $44.6 billion in 2011. With the rollout of at least eight new therapeutic ...

The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies), 4th Edition by Kalorama Information
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies) represents the fourth ...

The Global Competitive Landscape of Antibody Drug Development in Cancer: The Faster Route to Consider Your Options and Position of Others by BioSeeker Group AB
This report will excel your competitive awareness and decrease your decision making time in one of the fastest growing segments in the pharmaceutical market, namely ...

Therapeutic Monoclonal Antibodies: World Market 2011-2021 by Visiongain
How will the market for monoclonal antibody (mAb) therapies perform from 2011? Visiongain's report shows you potential revenues to 2021. Find opportunities and prospects. ...

See all reports like this >>

Monoclonal Antibody Based Products - Global Trends

Share this report

Other tasks

Research Assistance

Related Markets

Antibody Technologies Reports

Free Alert Me service